Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
392.54
-1.89 (-0.48%)
At close: Aug 31, 2026, 4:00 PM EDT
392.54
0.00 (0.00%)
After-hours: Aug 31, 2026, 7:30 PM EDT
Elevance Health Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Elevance Health stock has a consensus rating of "Buy" and an average price target of $449.1. The average 1-year stock price forecast is 14.41% higher than the current stock price, while the lowest is $393 (+0.12%) and the highest is $492 (+25.34%).
Price Target: $449.1 (+14.41%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 12 | 12 | 12 | 12 |
| Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Hold | 8 | 8 | 7 | 8 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Reiterates $488 | Buy | Reiterates | $488 | +24.32% | Aug 28, 2026 |
| Barclays | Barclays | Buy Reiterates $457 | Buy | Reiterates | $457 | +16.42% | Jul 20, 2026 |
| Leerink Partners | Leerink Partners | Hold Reiterates $364 → $395 | Hold | Reiterates | $364 → $395 | +0.63% | Jul 17, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $465 | Buy | Reiterates | $465 | +18.46% | Jul 17, 2026 |
| Jefferies | Jefferies | Buy Maintains $391 → $450 | Buy | Maintains | $391 → $450 | +14.64% | Jul 16, 2026 |
Financial Forecast
Revenue This Year
196.24B
from 199.13B
Decreased by -1.45%
Revenue Next Year
200.39B
from 196.24B
Increased by 2.12%
EPS This Year
27.16
from 30.29
Decreased by -10.33%
EPS Next Year
29.61
from 27.16
Increased by 9.00%
EPS and Forward PE are based on non-GAAP adjusted numbers.